Medicare Rx Outlook Hinges On Scope Of "Reform," Hill Staffers Say
Executive Summary
The outlook for Medicare prescription drug legislation in the 107th Congress depends on the scope of "Medicare reform" proposals that are attached to the bill, House Ways & Means/Health Subcommittee minority staff member Cybele Bjorkland told the Schwab Washington Research Group healthcare conference May 7 in Washington, D.C.
You may also be interested in...
PhRMA Staff Expansion May Help With New Medicare Rx Broker Baucus
PhRMA's federal affairs staff expansion includes a timely addition that should help the trade association work with incoming Finance Committee Chairman Baucus (D-Mont.).
PhRMA Staff Expansion May Help With New Medicare Rx Broker Baucus
PhRMA's federal affairs staff expansion includes a timely addition that should help the trade association work with incoming Finance Committee Chairman Baucus (D-Mont.).
Medicare Rx Budget Set-Aside May Not Be Enough For AARP
The $300 bil. budget set-aside for a Medicare prescription drug benefit may not be sufficient to cover low-income provisions of drug benefit proposals, AARP maintains.